EUVIMEDEUVIMED entdecken
Open Access

The peroxisome proliferator–activated receptor α/β/γ agonist NCPC-626 from microbial metabolites alleviates metabolic dysfunction–associated steatohepatitis in mice

Man Yu, Xiao Ren, Ruolan Li, Wenbin Shen, Baohua Zhao, Yeying Li, Xuelian Zhang, Xiaolan Cui, Jingtong Zhu, Xuexia Zhang, Lijie Wang, Xinhua Lu und 1 weitere

Molecular Pharmacology · 2025

DOI: 10.1016/j.molpha.2025.100065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmacology, 2025. Verfasst von Man Yu und 12 weiteren Autor:innen. Beteiligte Einrichtung: New Drug Research & Development Center, North China Pharmaceutical Group Corporation, Shijiazhuang, Hebei, China; National Engineering Research Cente…. Hauptthemen laut MEDLINE: PPAR alpha, PPAR gamma, Fatty Liver, PPAR-beta. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Hebei Provincial Department of Human Resources and Social Security.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PPAR alphaPPAR gammaFatty LiverPPAR-betaNon-alcoholic Fatty Liver DiseaseAnimalsMiceMaleMice, Inbred C57BLLiverHumansLipid Metabolism

Stichwörter der Autor:innen

AgonistHigh-throughput screeningMetabolic dysfunction–associated steatohepatitisPeroxisome proliferator–activated receptors

Substanzen

PPAR alphaPPAR gammaPPAR-beta

Autor:innen und Institutionen

  • New Drug Research & Development Center, North China Pharmaceutical Group Corporation, Shijiazhuang, Hebei, China; National Engineering Research Center of Microbial Medicine, Shijiazhuang, Hebei, China; Key Laboratory fo…
  • New Drug Research & Development Center, North China Pharmaceutical Group Corporation, Shijiazhuang, Hebei, China; Hebei Industry Microbial Metabolic Technology Innovation Center, Shijiazhuang, Hebei, China.
  • New Drug Research & Development Center, North China Pharmaceutical Group Corporation, Shijiazhuang, Hebei, China; National Engineering Research Center of Microbial Medicine, Shijiazhuang, Hebei, China.
  • New Drug Research & Development Center, North China Pharmaceutical Group Corporation, Shijiazhuang, Hebei, China; Key Laboratory for New Drug Screening Technology of Shijiazhuang City, Shijiazhuang, Hebei, China; Hebei…
  • Life Science of College, Hebei Normal University, Shijiazhuang, Hebei, China.
  • New Drug Research & Development Center, North China Pharmaceutical Group Corporation, Shijiazhuang, Hebei, China; National Engineering Research Center of Microbial Medicine, Shijiazhuang, Hebei, China; Hebei Industry Mi…

Förderung

  • Hebei Provincial Department of Human Resources and Social Security

Zitieren

APA

Yu, M., Ren, X., Li, R., Shen, W., Zhao, B., Li, Y., Zhang, X., Cui, X., Zhu, J., Zhang, X., Wang, L., Lu, X., & Zheng, Z. (2025). The peroxisome proliferator–activated receptor α/β/γ agonist NCPC-626 from microbial metabolites alleviates metabolic dysfunction–associated steatohepatitis in mice. Molecular Pharmacology. https://doi.org/10.1016/j.molpha.2025.100065

Vancouver

Yu M, Ren X, Li R, Shen W, Zhao B, Li Y, et al. The peroxisome proliferator–activated receptor α/β/γ agonist NCPC-626 from microbial metabolites alleviates metabolic dysfunction–associated steatohepatitis in mice. Molecular Pharmacology. 2025. doi:10.1016/j.molpha.2025.100065

BibTeX
@article{Yu2025,
  author = {Yu, Man and Ren, Xiao and Li, Ruolan and Shen, Wenbin and Zhao, Baohua and Li, Yeying and Zhang, Xuelian and Cui, Xiaolan and Zhu, Jingtong and Zhang, Xuexia and Wang, Lijie and Lu, Xinhua and Zheng, Zhihui},
  title = {The peroxisome proliferator–activated receptor α/β/γ agonist NCPC-626 from microbial metabolites alleviates metabolic dysfunction–associated steatohepatitis in mice},
  journal = {Molecular Pharmacology},
  year = {2025},
  doi = {10.1016/j.molpha.2025.100065}
}
Kostenlos starten →